PlainRecalls
FDA Drug Moderate Class II Terminated

Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.

Reported: January 1, 2014 Initiated: November 6, 2013 #D-388-2014

Product Description

Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.

Reason for Recall

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Details

Recalling Firm
GlaxoSmithKline, LLC.
Units Affected
9,743 cartridges
Distribution
Nationwide
Location
Zebulon, NC

Frequently Asked Questions

What product was recalled?
Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.. Recalled by GlaxoSmithKline, LLC.. Units affected: 9,743 cartridges.
Why was this product recalled?
Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 1, 2014. Severity: Moderate. Recall number: D-388-2014.